ACM Research (ACMR) Cash & Equivalents (2016 - 2026)

ACM Research (ACMR) has 11 years of Cash & Equivalents data on file, last reported at $872.3 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $872.3 million, up 90.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $872.3 million (up 90.77% YoY), and the FY2025 annual result was $757.4 million, up 85.88% from the prior year.
• Cash & Equivalents advanced to $872.3 million in Q1 2026 per ACMR's latest filing, from $757.4 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $1.1 billion in Q3 2025 and troughed at $182.1 million in Q4 2023.
• A 5-year average of $415.3 million and a median of $333.5 million in 2024 frame the typical range for Cash & Equivalents.
• On a YoY basis, Cash & Equivalents climbed as much as 421.22% in 2022 and fell as far as 55.92% in 2022.
• A 5-year view of Cash & Equivalents shows it stood at $248.0 million in 2022, then retreated by 26.56% to $182.1 million in 2023, then jumped by 123.76% to $407.4 million in 2024, then surged by 85.88% to $757.4 million in 2025, then advanced by 15.17% to $872.3 million in 2026.
• Business Quant data shows ACMR's Cash & Equivalents at $872.3 million in Q1 2026, $757.4 million in Q4 2025, and $1.1 billion in Q3 2025.